Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 10, 2021
Longevity Acquisition and 4D pharma have announced a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for BAVENCIO.
read more
Monday, February 01, 2021
RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib.
read more
Relief and Acer announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001.
read more
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more
Akston Biosciences and LakePharma have established a strategic partnership.
read more
Precision Dose is voluntarily recalling all lots of Chlorhexidine Gluconate Oral Rinse USP, 0.12%, 15mL Unit Dose Cups to the consumer level.
read more
Wednesday, January 06, 2021
Aurobindo Pharma and COVAXX have entered into an agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and UNICEF.
read more
Wednesday, January 06, 2021
Panthera’s clinical trial sites began dosing volunteers in the Phase III trial which will evaluate AstraZeneca’s long-acting antibody combination for the potential prevention of COVID-19.
read more
Tuesday, January 05, 2021
Slayback Pharma has received final approval for its ANDA for Merzee 1 mg/20 mcg from the FDA with a Competitive Generic Therapy Designation.
read more
Amgen announced the FDA has approved RIABNI, a biosimilar to Rituxan.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Monday, December 28, 2020
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a portfolio of select OTC and prescription pharmaceutical products from Takeda.
read more
Tuesday, December 22, 2020
Nabriva has announced the restructuring of its license agreement with Sinovant for XENLETA in the greater China region.
read more